Home>Topics>>Lexicon Pharma (LXRX) +8.5% premarket after its LX1033 drug candidate for irritable bowel syndrome receives fast track status from the FDA.
Lexicon Pharma (LXRX) +8.5% premarket after its LX1033 drug candidate for irritable bowel syndrome receives fast track status from the FDA.
Lexicon Pharma (
LXRX ) +8.5% premarket after its LX1033 drug candidate for irritable bowel syndrome receives fast track status from the FDA . Post your comment!
Read the rest of this article on SeekingAlpha.com: SA Currents